Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: Impact of compromised immunity

Journal of Viral Hepatitis

Volumn 17, Issue 8, 2010, Pages 578-587

  Sun, H Y ^a   Lee, H C ^b   Liu, C E ^c   Yang, C L ^a   Su, S C ^d   Ko, W C ^b   Lin, C Y ^a   Tsai, J J ^e   Wong, W W ^f   Ho, M W ^g   Cheng, S H ^h   Lin, Y H ⁱ   Miao, W J ^j   Hung, C C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h Taoyuan Hospital   (Taiwan)

ⁱ TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^j Mennonite Christian Hospital   (Taiwan)

more..

Author keywords

anti hepatitis B surface antibody; anti hepatitis C virus antibody; hepatitis B surface antigen; hepatitis B virus; HIV infection; isolated anti hepatitis B core antibody; occult hepatitis B virus infection

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA; VIRUS RNA; HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY ISOLATION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALE; MIRABILIS; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS LOAD; BLOOD; COMPLICATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL; TAIWAN; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; YOUNG ADULT;

EID: 77954490722     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01212.x     Document Type: Article

References (51)

1. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 2001 64 (3 312 319.
2. French AL, Operskalski E, Peters M et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis 2007 195 (10 1437 1442.
3. Osborn MK, Guest JL, Rimland D. Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease. HIV Med 2007 8 (5 271 279.
4. Jongjirawisan Y, Ungulkraiwit P, Sungkanuparph S. Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. J Med Assoc Thai 2006 89 (12 2028 2034.
5. Gandhi RT, Wurcel A, Lee H et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 2003 36 (12 1602 1605. (Pubitemid 36783346)
6. Gandhi RT, Wurcel A, Lee H et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis 2005 191 (9 1435 1441.
7. Gandhi RT, Wurcel A, McGovern B et al. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr 2003 34 (4 439 441. (Pubitemid 37444474)
8. Neau D, Winnock M, Galperine T et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 2004 5 (3 171 173.
9. Piroth L, Binquet C, Vergne M et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002 36 (5 681 686.
10. Sheng WH, Kao JH, Chen PJ et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2007 45 (9 1221 1229.
11. Hung CC, Hsiao CF. Isolated antibody to hepatitis B core antigen in individuals infected with HIV-1. Clin Infect Dis 2003 37 (9 1275 1276 author reply 1277.
12. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007 7 (6 402 409.
13. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975 292 (15 771 774.
14. Chen DS, Sung JL. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol (Stuttg) 1978 25 (6 423 430.
15. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007 106 (2 148 155.
16. Sun HY, Ko WC, Tsai JJ et al. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol 2009 104 (4 877 884.
17. Center for Disease Control Taiwan. Statistics of HIV/AIDS.
18. Yang CH, Huang YF, Hsiao CF et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med 2008 9 (7 535 543.
19. WHO. Hepatitis B, Vol. 2009. Available at: http://www.who.int/entity/csr/ disease/hepatitis/HepatitisB-whocdscsrlyo2002-2. pdf (affcessed on 4 April 2009). WHO, 2002.
20. Davaro RE, Cheeseman SH, Keroack MA, Ellison III. RT. The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus. Clin Infect Dis 1996 23 (1 189 190.
21. Perez-Rodriguez MT, Sopena B, Crespo M et al. Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients. World J Gastroenterol 2009 15 (10 1237 1241.
22. Rodriguez-Guardado A, Melon S, Rodriguez M, Asensi V, Carton JA, de Ona M. Influence of HCV genotype in isolated presence of antibody to hepatitis B core antigen in patients with HIV coinfection. J Acquir Immune Defic Syndr 2006 42 (5 647 649.
23. Guardado AR, Perez MR, Maradona JA, Martinez A, Asensi V, Carton JA. Isolated presence of antibody to hepatitis B core antigen in patients coinfected with HIV. J Acquir Immune Defic Syndr 2004 36 (4 988 989.
24. Vazquez-Vizoso F, Eiroa P, Ledo L, Anibarro L, Hernandez M, Ojea R. HIV infection and isolated detection of anti-HBc. Gastroenterology 1994 106 (3 823 824.
25. Rodriguez-Mendez ML, Gonzalez-Quintela A, Aguilera A, Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol 2000 95 (5 1316 1322.
26. Drake JH, Parmley RT, Britton HA. Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients. Pediatr Infect Dis J 1987 6 (11 1051 1054.
27. Laukamm-Josten U, Muller O, Bienzle U, Feldmeier H, Uy A, Guggenmoos-Holzmann I. Decline of naturally acquired antibodies to hepatitis B surface antigen in HIV-1 infected homosexual men. AIDS 1988 2 (5 400 401.
28. French AL, Lin MY, Evans CT et al. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis 2009 49 (1 148 154.
29. Knoll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J Gastroenterol 2006 12 (8 1255 1260.
30. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998 15 (1 1 8.
31. Dumoulin FL, von dem Bussche A, Li J et al. Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines. Virol 2003 305 (2 260 266.
32. Chen SY, Kao CF, Chen CM et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003 278 (1 591 607.
33. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002 37 (6 855 862.
34. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993 67 (10 5823 5832.
35. Chen DS, Hsu NH, Sung JL et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987 257 (19 2597 2603.
36. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002 100 (7 2637 2641.
37. Roth WK, Weber M, Petersen D et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002 42 (7 869 875.
38. Lo Re III. V, Frank I, Gross R et al. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 2007 44 (3 315 320.
39. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007 46 (1 160 170.
40. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998 17 (1 6 13.
41. Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004 36 (3 869 875.
42. Filippini P, Coppola N, Pisapia R et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 2006 20 (9 1253 1260.
43. Grob P, Jilg W, Bornhak H et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000 62 (4 450 455.
44. Firnhaber C, Viana R, Reyneke A et al. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis 2009 13 (14 488 492.
45. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006 35 (1 14 20.
46. Santos EA, Yoshida CF, Rolla VC et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003 22 (2 92 98.
47. Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen. Int J STD AIDS 2008 19 (3 197 199.
48. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 2009 81 (3 441 445.
49. Neau D, Winnock M, Jouvencel AC et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005 40 (5 750 753.
50. Wagner AA, Denis F, Weinbreck P et al. Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS 2004 18 (3 569 571.
51. Berger A, Doerr HW, Rabenau HF, Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology 2000 43 (2 71 76.